Table 1. Characteristics of asthma patients (All Caucasian).
Sample N | Diagnosis | Age | Gender | FEV11(%) | Treatment |
---|---|---|---|---|---|
638 | Asthma | 34 | Male | 86.7 | None |
662 | Asthma | 36 | Male | 76.2 | Symbicort2 (=ICS3+LABA4) |
667 | Asthma | 51 | Female | 58.2 | None |
669 | Asthma | 23 | Male | 75.3 | Symbicort (=ICS+LABA) |
670 | Asthma | 37 | Female | ND | None |
695 | Asthma | 56 | Male | 87.4 | None |
738 | Asthma | 77 | Female | 41.2 | None |
739 | Asthma | 64 | Male | 35.2 | Symbicort (=ICS+LABA) |
FEV1 – Forced Expiratory Volume in 1 second
Symbicort - a combination of anti-inflammatory and bronchodilator medicines.
ICS – Inhaled Corticosteroids
LABA – Long-Acting Beta Agonists